ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Geriatric Medicine

Top Geriatric Medicine Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ANTHONY NGUYEN D.O.

Geriatric Medicine

12,108

$1.37M

730
673 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

22%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 27%

$113
Average prescription price

Avg: $64

FRANCISCO RUGAMA MD

Geriatric Medicine

11,595

$1.02M

444
353 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

27%
patients receiving schedule three controlled substances

Avg: 17%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 27%

$88
Average prescription price

Avg: $64

STEVEN LEVY D.O.

Geriatric Medicine

11,523

$514K

477
426 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

12%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 27%

$45
Average prescription price

Avg: $64

JOSE ROSADO MORALES MD

Geriatric Medicine

11,169

$623K

385
314 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

32%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $64

ROWLAND REYNA M.D.

Geriatric Medicine

10,904

$731K

665
538 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

20%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 27%

$67
Average prescription price

Avg: $64

MARINA VENGALIL

Geriatric Medicine

10,903

$829K

575
516 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 27%

$76
Average prescription price

Avg: $64

SURAINDER AJMANI M.D.

Geriatric Medicine

10,840

$734K

320
220 are 65+

13%
patients receiving schedule two controlled substances

Avg: 2%

24%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 27%

$68
Average prescription price

Avg: $64

RICHARD STRICKLAND M.D.

Geriatric Medicine

10,458

$558K

280
264 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

31%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 27%

$53
Average prescription price

Avg: $64

APARNA KOTAMARTI

Geriatric Medicine

10,065

$492K

444
407 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

24%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 27%

$49
Average prescription price

Avg: $64

GNANA SUMATHI NAINI M.D.

Geriatric Medicine

9,987

$662K

299
243 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

27%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$66
Average prescription price

Avg: $64

RAKESH KATHPALIA MD

Geriatric Medicine

9,875

$514K

291
288 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

21%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$52
Average prescription price

Avg: $64

MAMATHA MODEM M.D

Geriatric Medicine

9,292

$460K

502
489 are 65+

7%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 27%

$49
Average prescription price

Avg: $64

YOUCEF SENNOUR MD

Geriatric Medicine

9,078

$650K

563
507 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

24%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 27%

$72
Average prescription price

Avg: $64

NADEEM JAMIL MD

Geriatric Medicine

9,056

$623K

601
520 are 65+

2%
patients receiving schedule two controlled substances

Avg: 2%

18%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 27%

$69
Average prescription price

Avg: $64

MAHENAAZ HAQ M.D.

Geriatric Medicine

8,898

$568K

632
624 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$64
Average prescription price

Avg: $64

GUILFORD ROBINSON M.D.

Geriatric Medicine

8,870

$685K

222
182 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

16%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 27%

$77
Average prescription price

Avg: $64

WILLIAM BELT MD

Geriatric Medicine

8,845

$582K

454
385 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

15%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$66
Average prescription price

Avg: $64

GEORGE THOMAS M.D.

Geriatric Medicine

8,446

$543K

375
358 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 27%

$64
Average prescription price

Avg: $64

ANN GOTSCHALL MD

Geriatric Medicine

8,354

$359K

371
252 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 27%

$43
Average prescription price

Avg: $64

JANICE KNEBL DO

Geriatric Medicine

8,064

$550K

292
286 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

23%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 27%

$68
Average prescription price

Avg: $64

VINOD KAUSHIK M.D.

Geriatric Medicine

8,027

$421K

338
331 are 65+

7%
patients receiving schedule two controlled substances

Avg: 2%

28%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 27%

$52
Average prescription price

Avg: $64

SANTOS SOBERON M.D.

Geriatric Medicine

7,765

$471K

331
289 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

17%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $64

NORBERTO MONTANI MD

Geriatric Medicine

7,179

$432K

276
245 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

24%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 27%

$60
Average prescription price

Avg: $64

ANDRES BONELLI MD

Geriatric Medicine

7,139

$435K

293
264 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

20%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $64

MARY MAXWELL M.D.

Geriatric Medicine

6,978

$437K

158
147 are 65+

11%
patients receiving schedule two controlled substances

Avg: 2%

15%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$63
Average prescription price

Avg: $64

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank